The effective use of ADA in bioprocessing, though, requires a multidisciplinary team, from a program lead and subject-matter ...
People with diabetes have a higher risk of developing Alzheimer's disease (AD) raising a possible link between the cells that ...
Reusing buffers in downstream operations would help biopharmaceutical manufacturers significantly reduce water consumption, making production more sustainable and cost efficient.
A new, streamlined AAV purification process that is both universal and scalable could ease commercialization constraint.
Lumi is available for early-stage process development. Reach Industries hopes to eventually offer the system for use in GMP compliancy.
Researchers identify glucose usage as one major divergence betweenT cells expanding in vitro versus those expanding in vivo.
Antibody-RNA Conjugates represent a significant advancement in the treatment of challenging and rare diseases with unmet medical need.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback